iBio to Participate in the 33rd Annual Roth Conference

Rhea-AI Summary

iBio will participate in the 33rd Annual Roth Conference held virtually from March 15-17, 2021. A pre-recorded presentation will be accessible on demand for all registered attendees. Starting March 15, the presentation will also be available on iBio's website under 'News & Events' in the Investors section. iBio is known for its FastPharming® System, which integrates advanced farming and glycosylation technologies to produce monoclonal antibodies, vaccines, and more. The company focuses on biopharmaceutical development targeting fibrotic and infectious diseases.

BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it will participate in the 33^rd Annual Roth Conference, which will be held virtually from March 15-17, 2021.

iBio's pre-recorded presentation will be available on demand during the virtual event for all registered attendees. Beginning on Monday, March 15, 2021, the presentation will also be available on the Company's website at www.ibioinc.com under "News & Events" in the Investors section.

About iBio, Inc.

iBio is a global leader in plant-based biologics manufacturing. Its FastPharming^® System combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing proprietary products on the FastPharming Platform, which include biopharmaceuticals for the treatment of fibrotic and infectious diseases, amongst others. The Company’s subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services, including Glycaneering™ Development Services for advanced recombinant protein design. For more information, visit www.ibioinc.com.

Contact:

Stephen Kilmer
iBio, Inc.
Investor Relations
(646) 274-3580
skilmer@ibioinc.com

FAQ

When is iBio participating in the Roth Conference?

iBio will participate in the Roth Conference from March 15-17, 2021.

How can I access iBio's presentation at the Roth Conference?

iBio's pre-recorded presentation will be available on demand for registered attendees and on iBio's website starting March 15, 2021.

What is the FastPharming system used by iBio?

The FastPharming system combines vertical farming and automated hydroponics to produce high-quality biologics like monoclonal antibodies and vaccines.

What type of products is iBio developing?

iBio is developing biopharmaceuticals for fibrotic and infectious diseases using its FastPharming platform.

What services does iBio CDMO LLC provide?

iBio CDMO LLC offers FastPharming Contract Development and Manufacturing Services, including Glycaneering Development Services.